| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.035 | 0.4 |